Intranasal fentanyl in the treatment of acute paina systematic review

Acta Anaesthesiologica Scandinavica

Volumn 56, Issue 4, 2012, Pages 407-419

  Hansen, M S ^a   Mathiesen, O ^a   Trautner, S ^a   Dahl, J B ^b  

^a University of Copenhagen   (Denmark)

^b Falck Danmark A/S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; MORPHINE; PLACEBO;

ANALGESIA; ANALGESIC ACTIVITY; BURN; CANCER PAIN; FRACTURE; HUMAN; MICTURITION CYSTOURETHROGRAPHY; MYRINGOTOMY; NAUSEA; PAIN; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; VERTIGO; VOMITING;

ACUTE PAIN; ADMINISTRATION, INTRANASAL; ANALGESICS, OPIOID; BREAKTHROUGH PAIN; FENTANYL; HUMANS; PAIN, POSTOPERATIVE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84858708250     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2011.02613.x     Document Type: Review

References (58)

1. Moksnes K, Fredheim OM, Klepstad P, Kaasa S, Angelsen A, Nilsen T, Dale O,. Early pharmacokinetics of nasal fentanyl: is there a significant arterio-venous difference? Eur J Clin Pharmacol 2008; 64: 497-502.
2. Dale O, Hjortkjaer R, Kharasch ED,. Nasal administration of opioids for pain management in adults. Acta Anaesthesiol Scand 2002; 46: 759-770.
3. Christrup LL, Foster D, Popper LD, Troen T, Upton R,. Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: a randomized, double-blind, double-dummy, two-way, crossover study. Clin Ther 2008; 30: 469-481.
4. Foster D, Upton R, Christrup L, Popper L,. Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery. Ann Pharmacother 2008; 42: 1380-1387.
5. Panagiotou I, Mystakidou K,. Intranasal fentanyl: from pharmacokinetics and bioavailability to current treatment applications. Expert Rev Anticancer Ther 2010; 10: 1009-1021.
6. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ,. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
7. Greenfield ML, Mhyre JM, Mashour GA, Blum JM, Yen EC, Rosenberg AL,. Improvement in the quality of randomized controlled trials among general anesthesiology journals 2000 to 2006: a 6-year follow-up. Anesth Analg 2009; 108: 1916-1921.
8. Moher D, Liberati A, Tetzlaff J, Altman DG,. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010; 8: 336-341.
9. Garner D,. Randomized controlled trial of intranasal fentanyl versus intravenous morphine for pain relief in pre-hospital care â∥ proceedings title. J Emerg Prim Health Care 2006; 4: 6.
10. Wilkes G, Oxer H, Jonhston S,. Inhaled methoxyflurane and intranasal fentanyl provide effective prehospital analgesia. CJEM 2006; 8: S103.
11. Veldhorst-Janssen NM, Fiddelers AA, van der, Kuy PH, Kessels AG, Theunissen HM, van der, Hulst RR, Neef C, Marcus MA,. Pharmacokinetics, analgesic effect, and tolerability of a single preprocedural dose of intranasal fentanyl in patients undergoing drain removal after breast reduction or augmentation surgery: a prospective, randomized, double-blind, placebo-controlled study. Clin Ther 2010; 32: 1427-1436.
12. Finn J, Wright J, Fong J, Mackenzie E, Wood F, Leslie G, Gelavis A,. A randomised crossover trial of patient controlled intranasal fentanyl and oral morphine for procedural wound care in adult patients with burns. Burns 2004; 30: 262-268.
13. Striebel HW, Pommerening J, Rieger A,. Intranasal fentanyl titration for postoperative pain management in an unselected population. Anaesthesia 1993; 48: 753-757.
14. Striebel HW, Koenigs D, Kramer J,. Postoperative pain management by intranasal demand-adapted fentanyl titration. Anesthesiology 1992; 77: 281-285.
15. Toussaint S, Maidl J, Schwagmeier R, Striebel HW,. Patient-controlled intranasal analgesia: effective alternative to intravenous PCA for postoperative pain relief. Can J Anaesth 2000; 47: 299-302.
16. Portenoy RK, Burton AW, Gabrail N, Taylor D,. A multicenter, placebo-controlled, double-blind, multiple-crossover study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain. Pain 2010; 151: 617-624.
17. Kress HG, Oronska A, Kaczmarek Z, Kaasa S, Colberg T, Nolte T,. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period. Clin Ther 2009; 31: 1177-1191.
18. Davies A, Sitte T, Elsner F, Reale C, Espinosa J, Brooks D, Fallon M,. Consistency of efficacy, patient acceptability, and nasal tolerability of fentanyl pectin nasal spray compared with immediate-release morphine sulfate in breakthrough cancer pain. J Pain Symptom Manage 2011; 41: 358-366.
19. Taylor D, Galan V, Weinstein SM, Reyes E, Pupo-Araya AR, Rauck R,. Fentanyl pectin nasal spray in breakthrough cancer pain. J Support Oncol 2010; 8: 184-190.
20. Galinkin JL, Fazi LM, Cuy RM, Chiavacci RM, Kurth CD, Shah UK, Jacobs IN, Watcha MF,. Use of intranasal fentanyl in children undergoing myringotomy and tube placement during halothane and sevoflurane anesthesia. Anesthesiology 2000; 93: 1378-1383.
21. Borland M, Jacobs I, King B, OBrien D,. A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department. Ann Emerg Med 2007; 49: 335-340.
22. Chung S, Lim R, Goldman RD,. Intranasal fentanyl versus placebo for pain in children during catheterization for voiding cystourethrography. Pediatr Radiol 2010; 40: 1236-1240.
23. Voronov P, Tobin MJ, Billings K, Cote CJ, Iyer A, Suresh S,. Postoperative pain relief in infants undergoing myringotomy and tube placement: comparison of a novel regional anesthetic block to intranasal fentanyl-a pilot analysis. Paediatr Anaesth 2008; 18: 1196-1201.
24. Borland ML, Bergesio R, Pascoe EM, Turner S, Woodger S,. Intranasal fentanyl is an equivalent analgesic to oral morphine in paediatric burns patients for dressing changes: a randomised double blind crossover study. Burns 2005; 31: 831-837.
25. Manjushree R, Lahiri A, Ghosh BR, Laha A, Handa K,. Intranasal fentanyl provides adequate postoperative analgesia in pediatric patients. Can J Anaesth 2002; 49: 190-193.
26. Rampersad S, Jimenez N, Bradford H, Seidel K, Lynn A,. Two-agent analgesia versus acetaminophen in children having bilateral myringotomies and tubes surgery. Paediatr Anaesth 2010; 20: 1028-1035.
27. Gourlay GK, Kowalski SR, Plummer JL, Cousins MJ, Armstrong PJ,. Fentanyl blood concentration-analgesic response relationship in the treatment of postoperative pain. Anesth Analg 1988; 67: 329-337.
28. Rickard C, OMeara P, McGrail M, Garner D, McLean A, Le Lievre P,. A randomized controlled trial of intranasal fentanyl vs intravenous morphine for analgesia in the prehospital setting. Am J Emerg Med 2007; 25: 911-917.
29. Fisher A, Watling M, Smith A, Knight A,. Pharmacokinetic comparisons of three nasal fentanyl formulations; pectin, chitosan and chitosan-poloxamer 188. Int J Clin Pharmacol Ther 2010; 48: 138-145.
30. Abboud T, Zhu J, Gangolly J, Longhitano M, Swart F, Makar A,. Transnasal butorphanol; a new method for pain relief in post-cesarean section pain. Acta Anaesthesiol Scand 1991; 35: 14-18.
31. Schwesinger W, Reynolds J, Harshaw D, Frakes L,. Transnasal butorphanol and intramuscular meripidine in the treatment of postoperative pain. Adv Ther 1992; 9: 123-129.
32. Wermeling DP, Grant GM, Lee A, Alexander N, Rudy AC,. Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: a randomized, double-blind, placebo-controlled, parallel-group study. Clin Ther 2005; 27: 430-440.
33. Telfer P, Criddle J, Sandell J, Davies F, Morrison I, Challands J,. Intranasal diamorphine for acute sickle cell pain. Arch Dis Child 2009; 94: 979-980.
34. Kendall JM, Reeves BC, Latter VS,. Multicentre randomised controlled trial of nasal diamorphine for analgesia in children and teenagers with clinical fractures. BMJ 2001; 322: 261-265.
35. Striebel W, Malewicz J, Hermanns K, Castello R,. Intranasal meripedine titration for postoperative pain relief. Anesth Analg 1993; 76: 1047-1051.
36. Mathieu N, Cnudde N, Engelman E, Barvais L,. Intranasal sufentanil is effective for postoperative analgesia in adults. Can J Anaesth 2006; 53: 60-66.
37. Anez Simon C, Rull Bartomeu M, Rodriguez Perez A, Fuentes Baena A,. [Intranasal opioids for acute pain]. Rev Esp Anestesiol Reanim 2006; 53: 643-652.
38. Cheng X, Li JH,. [Effects of fentanyl administrated nasally and intravenously in post-operative analgesia in pediatric children: a comparative study of 36 cases]. Zhonghua Yi Xue Za Zhi 2008; 88: 2898-2900.
39. Marxer N,. Fentanyl-containing nasal spray. Krankenhauspharmazie 2009; 30: 437-440.
40. Sandner F,. Fentanyl nasal spray against breakthrough pain: pain relief after only 5 minutes. J Pharm Therapie 2009; 18: 133.
41. Schwagmeier R, Oelmann T, Dannappel T, Striebel HW,. [Patient acceptance of patient-controlled intranasal analgesia (PCINA)]. Anaesthesist 1996; 45: 231-234.
42. Striebel HW, Kopf A, Holzl M, Schwagmeier R,. Intranasal opioid administration in pain management-a new application route. Anasthesiol Intensivmed 1996; 37: 128-134.
43. Striebel HW, Kramer J, Luhmann I, Rohierse-Hohler I, Rieger A,. [Pharmacokinetics of intranasal Fentanyl.]. Schmerz 1993; 7: 122-125.
44. Striebel HW, Wessel A, Rieger A,. [Intranasal fentanyl for breakthrough cancer pain. A pilot study.]. Schmerz 1993; 7: 174-177.
45. Fallon M, Gatti A, Davies A, Lux EA, Kumar K, Galvez R,. Efficacy, safety and patient acceptability of fentanyl pectin nasal spray compared with immediate-release morphine sulphate tablets in the treatment of breakthrough cancer pain: a multicentre, double-blind, double-dummy, multiple-crossover study. Eur J Cancer 2009; 7: 15.
46. Kress HG, Colberg T,. Titration of intranasal fentanyl spray (INFS) for breakthrough pain in cancer patients: evidence for dose proportionality vs. background analgesia. Eur J Pain 2009; 13: 197.
47. Nave R, Sides EH, Colberg T, Lophaven S, Meng X, Lahu G, Schmitt H,. Higher systemic bioavailability and faster absorption of intranasal fentanyl spray (INFS) compared to actiq (OTFC) in healthy subjects. Eur J Pain 2009; 13: 206-207.
48. Oyee J, Thomson A, Asmussen M, Phillips Z,. Budget impact of intranasal fentanyl spray to treat breakthrough pain in cancer patients. Palliat Med 2010; 24: 223.
49. Wong P, Chadwick FD, Karovits J,. Intranasal fentanyl for postoperative analgesia after elective Caesarean section. Anaesthesia 2003; 58: 818-819.
50. Striebel HW, Oelmann T, Spies C, Rieger A, Schwagmeier R,. Patient-controlled intranasal analgesia: a method for noninvasive postoperative pain management. Anesth Analg 1996; 83: 548-551.
51. Striebel HW, Olmann T, Spies C, Brummer G,. Patient-controlled intranasal analgesia (PCINA) for the management of postoperative pain: a pilot study. J Clin Anesth 1996; 8: 4-8.
52. Younge P, Nicol M, Kendall J, Harrington A,. A prospective randomized pilot comparison of intranasal fentanyl and intramuscula morphine for analgesia in children presenting to the emergency department with clinical fractures. Emerg Med 1999; 11: 90-94.
53. Paech MJ, Lim CB, Banks SL, Rucklidge MW, Doherty DA,. A new formulation of nasal fentanyl spray for postoperative analgesia: a pilot study. Anaesthesia 2003; 58: 740-744.
54. Mercadante S, Radbruch L, Davies A, Poulain P, Sitte T, Perkins P, Colberg T, Camba MA,. A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial. Curr Med Res Opin 2009; 25: 2805-2815.
55. Zeppetella G,. An assessment of the safety, efficacy, and acceptability of intranasal fentanyl citrate in the management of cancer-related breakthrough pain: a pilot study. J Pain Symptom Manage 2000; 20: 253-258.
56. Cole J, Shepherd M, Young P,. Intranasal fentanyl in 1-3-year-olds: a prospective study of the effectiveness of intranasal fentanyl as acute analgesia. Emerg Med Australas 2009; 21: 395-400.
57. Portenoy RK, Raffaeli W, Torres LM, Sitte T, Deka AC, Herrera IG, Wallace MS,. Long-term safety, tolerability, and consistency of effect of fentanyl pectin nasal spray for breakthrough cancer pain in opioid-tolerant patients. J Opioid Manag 2010; 6: 319-328.
58. Saunders M, Adelgais K, Nelson D,. Use of intranasal fentanyl for the relief of pediatric orthopedic trauma pain. Acad Emerg Med 2010; 17: 1155-1161.